Latest News

  • Danger Ahead: How AI-Enabled Remote Cardiac Monitoring Technology Can Mitigate the Growing AFib Crisis

    Diagnostics World | Atrial Fibrillation (AFib) is a fast-growing public health crisis—three times more common than once thought. Today, at least 10.55 million US adults have AFib, far exceeding the 3.3 million cases researchers predicted for the year 2020 in 1996. And this crisis is only growing.

    Apr 4, 2025

  • Babson Diagnostics’ BetterWay Blood Test Available at National Retailer

    Diagnostics World | Last week, Babson Diagnostics entered an agreement with Sam’s Club to offer BetterWay blood testing. BetterWay is currently available in seven Sam’s Club pharmacies in the greater Austin area. The agreement with Sam’s Club marks a significant milestone for accessible blood testing for patients.

    Apr 3, 2025

  • Texas District Court Vacates FDA LDT Rule

    Diagnostics World | The U.S. District Court for the Eastern District of Texas granted a motion for summary judgment yesterday, vacating the FDA rule that would have regulated LDTs as medical devices under the Federal Food, Drug and Cosmetic Act.

    Apr 1, 2025

  • PathAI’s Pathology Assessment Tool, Mayo Clinic Collaboration, More

    Diagnostics World | PathAI received full qualification for AIM-MASH AI Assist1; Mayo Clinic Laboratories and Amprion announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the United States; and more.

    Mar 27, 2025

  • Follow the Money: Shingles Vaccine, Blood Stem Cell Therapies, More

    Diagnostics World | Curevo will advance development of amezosvatein, the company’s vaccine for shingles; Garuda aims to address the growing need for off-the-shelf and cost-effective solution to stem cell transplants; and more.

    Mar 26, 2025

  • GE HealthCare, NVIDIA Pursue Autonomous X-Ray, Ultrasound

    Diagnostics World | GE HealthCare announced a collaboration this week with NVIDIA, expanding the existing 16-year relationship between the two companies to focus on pioneering innovation in autonomous imaging, beginning with autonomous X-ray technologies and autonomous applications within ultrasound.

    Mar 20, 2025

  • Device Predicts Metastatic Risk by Measuring Stickiness of Cancer Cells

    Diagnostics World | Based on the discovery that the adhesion strength of cancer cells scales inversely proportional to the invasiveness of a tumor, researchers at University of California, San Diego have built a microfluidic device with the hope that it can be used in the future to diagnose the metastatic potential of ductal carcinoma in situ (DCIS) breast cancer tumors.

    Mar 19, 2025

  • Early Bladder Cancer Detection Just the Beginning for This At-Home Urine Test

    Diagnostics World | The incidence of bladder cancer is rising significantly due to population aging and, while survival rates are relatively high, when diagnosed late patients may need to undergo bladder removal regardless of survival. Early detection and treatment of bladder cancer are therefore crucial to preserving the organ and maintaining the patient’s quality of life.

    Mar 18, 2025